FindTrial
Sign In

Weekly Vindesine as Second-line Chemotherapy in Pediatric Low-Grade Glioma

Weekly Vindesine as Second-line Chemotherapy in Pediatric Low-Grade Glioma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500102311
Enrollment
Unknown
Registered
2025-05-13
Start date
2025-05-13
Completion date
Unknown
Last updated
2025-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low grade glioma

Interventions

Observation group:None

Sponsors

Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 15 Years

Inclusion criteria

Inclusion criteria: 1. Pathology confirmed low grade glioma,; 2. Develop carboplatin hypersensitivity reaction during first-line chemotherapy of carboplatin and vincristine;

Exclusion criteria

Exclusion criteria: 1.brain tumor without pathology confirmation;

Design outcomes

Primary

MeasureTime frame
Common Terminology Criteria for Adverse Events;—

Countries

China

Contacts

Public ContactYijin Gao

Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine

gaoyijin@scmc.com.cn+86 21 3862 6161

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026